Deignan Charles A. 4
4 · Clearside Biomedical, Inc. · Filed Sep 20, 2023
Insider Transaction Report
Form 4
Deignan Charles A.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-09-18+100,000→ 100,000 totalExercise: $0.85Exp: 2033-09-18→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]One-third of the shares underlying this option vest on September 18, 2024 and the balance of the shares vest in a series of 24 successive equal monthly installments thereafter, subject to the Reporting Person's continuous service as of each such vesting date.